How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Our reviewer committed to trying Noom long-term for 1 year. Noom focuses on behavioral changes, referring to itself as a lifestyle rather than a diet. Noom offerings include Noom Vibe, a support app ...

A secure password can be hard to remember. It’s long and littered with symbols and numbers you may struggle to recall. That difficulty helps explain why nearly half of US adults (49%) end up with ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...